Patents by Inventor Ruth E. Winter

Ruth E. Winter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNE CELL FUNCTION
    Publication number: 20260098074
    Abstract: The present disclosure relates to the field of cell therapy, and more specifically, to improving CAR and/or TCR function through improvement of improvement of cytokine signaling.
    Type: Application
    Filed: July 15, 2025
    Publication date: April 9, 2026
    Inventors: Ruth E. Winter, Saikat Banerjee
  • Immune cell function
    Patent number: 12454563
    Abstract: The present disclosure relates to the field of cell therapy, and more specifically, to improving CAR and/or TCR function through improvement of cytokine signaling. Disclosed are embodiments of a membrane bound interleukin 15 (IL-15)-IL-15Ralpha sushi domain chimeric receptor. The chimeric receptor may comprise a FAS transmembrane domain or an IL-7 transmembrane domain. Different embodiments of the chimeric receptor have different polypeptide lengths between the IL-15 region and the transmembrane domain.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: October 28, 2025
    Assignee: Kite Pharma, Inc.
    Inventors: Ruth E. Winter, Saikat Banerjee
  • IMMUNE CELL FUNCTION
    Publication number: 20220289815
    Abstract: The present disclosure relates to the field of cell therapy, and more specifically, to improving CAR and/or TCR function through improvement of improvement of cytokine signaling.
    Type: Application
    Filed: March 9, 2022
    Publication date: September 15, 2022
    Inventors: Ruth E. Winter, Saikat Banerjee
  • Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens
    Patent number: 5474905
    Abstract: The present invention relates to the isolation of newly discovered hemin/hemoglobin-binding proteins of Streptococcus pneumoniae with approximate molecular weights of 18, 43, 55, 66 and 76 kDa, respectively, thereby providing bacterial-derived antigens and active derivatives and parts thereof, useful in the diagnostic assays, vaccines and pharmaceutical compositions relative to these bacteria. In addition, the present invention is directed to polyclonal and monoclonal antibodies directed to the hemin/hemoglobin-binding proteins of Streptococcus pneumoniae. The present invention further relates to methods of diagnosing and treating human pneumococcal infections including kits therefor.
    Type: Grant
    Filed: November 24, 1993
    Date of Patent: December 12, 1995
    Assignee: Research Corporation Technologies
    Inventors: Stanley S. Tai, Ruth E. Winter